Australian Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Australian Biotechnologies's estimated annual revenue is currently $17.1M per year.
- Australian Biotechnologies's estimated revenue per employee is $251,000
Employee Data
- Australian Biotechnologies has 68 Employees.
- Australian Biotechnologies grew their employee count by 1% last year.
Australian Biotechnologies's People
Name | Title | Email/Phone |
---|---|---|
1 | Quality Officer | Reveal Email/Phone |
2 | Quality Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Quality Assurance Officer | Reveal Email/Phone |
5 | Production Manager -TGA Nominee | Reveal Email/Phone |
6 | Product Manager - Spine Biologics | Reveal Email/Phone |
7 | National Allograft Product Specialist Manager | Reveal Email/Phone |
8 | Manufacturing Compliance Manager | Reveal Email/Phone |
9 | People and Culture Manager | Reveal Email/Phone |
10 | Tissue Procurement Manager | Reveal Email/Phone |
Australian Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $182.7M | 520 | 22% | $124.5M | N/A |
#2 | $33.9M | 135 | -2% | N/A | N/A |
#3 | $5.4M | 43 | -23% | $20.8M | N/A |
#4 | $14.3M | 57 | 10% | N/A | N/A |
#5 | $33.4M | 133 | -13% | $5M | N/A |
#6 | $19.3M | 77 | 8% | N/A | N/A |
#7 | $28.4M | 113 | -3% | N/A | N/A |
#8 | $257.3M | 1025 | 0% | N/A | N/A |
#9 | $22.6M | 90 | -2% | N/A | N/A |
#10 | $35.9M | 143 | 8% | N/A | N/A |
What Is Australian Biotechnologies?
Australian Biotechnologies Pty Ltd was founded in 2000 and is located in Frenchs Forest, New South Wales, Australia. World class processing facilities specially trained technical staff and strict quality procedures the company is the first privately owned and operated tissue-processing facility in Australia. Australian Biotechnologies is licensed by the Therapeutic Goods Administration (Australian Federal Government) to retrieve, process and distribute donated human bone and tissue for transplant purposes. Working with agencies of the Australian Government, tissue donation programs and our international technology partners, we strive to make the safest and most advanced natural allograft products available to Australian surgeons and their patients. Australian Biotechnologies manufactures and distributes Life enhancing allograft tissue products for the Australian community. Australian Biotechnologies is a full service provider of allograft processing solutions, and manufactures a range of allografts for use in the following surgical areas: Spinal surgery Dental procedures Orthopaedics Oral-maxillofacial Sports medicine Trauma Allografts manufactured by Australian Biotechnologies are manufactured for and on behalf of our Donation Partners. Australian Biotechnologies provide allograft processing services for the following donation with Australian Tissue Donation Network. Australian Tissue Donation Network is a not-for-profit national donation agency whose mission is to raise awareness of tissue donation and facilitate the donation process. With a femoral head donation program successfully established in 25 hospitals across Australia, Australian Tissue Donation Network are committed to the continued expansion of the provision of services to Australians who wish to donate their tissue as a precious gift for those in need. For more information, visit http://tissuedonationnetwork.org.au
keywords:N/AN/A
Total Funding
68
Number of Employees
$17.1M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Australian Biotechnologies News
Ansa Biotechnologies ties up $68M for DNA synthesis platform ... Pfizer, through its Australian subsidiary, has proposed a deal to acquire...
We selected FUJIFILM Diosynth Biotechnologies as our ... The Australian government recently invested $7.7 million in Alcoa Corp.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.5M | 79 | 5% | N/A |
#2 | $22.6M | 90 | -2% | N/A |
#3 | $18.7M | 93 | 2% | N/A |
#4 | N/A | 153 | 43% | N/A |
#5 | $52.3M | 164 | 9% | N/A |